Olmesar 40 Tablet (15)
- Manufactured by: Macleods Pharmaceuticals Pvt Ltd
- Contains / Salt: Olmesartan (40 mg)
Olmesar 40 Tablet (15)
Prescription Required
172 people have bought this recently
- Manufactured by: Macleods Pharmaceuticals Pvt Ltd
- Contains / Salt: Olmesartan (40 mg)
Seller: Apollo Pharmacy Limited
- This medicine is not available on Cash on Delivery(CoD)
Olmesar 40 Tablet (15) Information
Olmesar 40 Tablet (15), a prescription drug, is manufactured in various forms such as Tablet. High BP are some of its major therapeutic uses. Olmesar 40 Tablet (15) also has some secondary and off-label uses. These are listed below.
The right dosage of Olmesar 40 Tablet (15) depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Olmesar 40 Tablet (15) are Upper respiratory tract infection. Apart from the aforementioned side effects, Olmesar 40 Tablet (15) can also lead to other problems, which have been listed below. Such side effects of Olmesar 40 Tablet (15) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Olmesar 40 Tablet (15) is Severe for pregnant women and Mild for women who are breastfeeding. In addition, Olmesar 40 Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Olmesar 40 Tablet (15) related warnings section.
Olmesar 40 Tablet (15) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Olmesar 40 Tablet (15) in conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension). The section on Olmesar 40 Tablet (15) contraindications lists all such conditions.
Besides this, Olmesar 40 Tablet (15) may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Olmesar 40 Tablet (15) is not safe while driving, and is is not addictive in nature.
Olmesar 40 Tablet (15) Benefits & Uses
Olmesar 40 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
Olmesar 40 Tablet (15) Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Olmesar 40 Tablet (15) Related Warnings
-
Is the use of Olmesar 40 Tablet (15) safe for pregnant women?
Pregnant women may get severe side effects after taking Olmesar. If you are pregnant, do not take Olmesar without a doctor's advice.
Severe -
Is the use of Olmesar 40 Tablet (15) safe during breastfeeding?
Olmesar may have very limited harmful effects for breastfeeding women.
Mild -
What is the effect of Olmesar 40 Tablet (15) on the Kidneys?
Olmesar has very mild side effects on the kidneys.
Mild -
What is the effect of Olmesar 40 Tablet (15) on the Liver?
Olmesar may have mild side effects on the liver. Most people will never see any effect on the liver.
Mild -
What is the effect of Olmesar 40 Tablet (15) on the Heart?
Olmesar may have mild side effects on the heart. Most people will never see any effect on the heart.
Mild
Severe Interaction of Olmesar 40 Tablet (15) with Other Drugs
Olmesar 40 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Olmesar 40 Tablet (15) Contraindications
If you are suffering from any of the following diseases, you should not take Olmesar 40 Tablet (15) unless your doctor advises you to do so -
- Diabetes
- Bradycardia (Slow Heart Rate)
- Low Blood Pressure
- Kidney Disease
- Liver Disease
Frequently asked Questions about Olmesar 40 Tablet (15)
-
Is this Olmesar 40 Tablet (15) habit forming or addictive?
Olmesar 40 Tablet (15) does not cause addiction.
No -
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Olmesar 40 Tablet (15) can make you feel drowsy.
Dangerous -
Is it safe?
Yes, but take Olmesar 40 Tablet (15) only as per medical advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
There is no benefit of taking Olmesar 40 Tablet (15) for mental disorders.
No
Olmesar 40 Tablet (15) Interactions with Food and Alcohol
-
Interaction between Food and Olmesar 40 Tablet (15)
Eating certain foods may increase the time it takes Olmesar 40 Tablet (15) to have an effect. You should consult your doctor about it.
Mild -
Interaction between Alcohol and Olmesar 40 Tablet (15)
Taking alcohol with Olmesar 40 Tablet (15) can be dangerous.
Severe
See all substitutes for Olmesar
- Olmat 40 Tablet - ₹160.6
- Olmecip 40 Tablet - ₹197.1
- Olmesar 20 Tablet (15) - ₹163.4
- Olmetime 20 Tablet - ₹55.5
- Olmezest 20 Tablet - ₹107.4
- Olmezest 40 Tablet - ₹185.3
- Olmighty 20 Tablet - ₹46.3
- Olmy 10 Tablet - ₹107.4
- Olvance 20 Tablet - ₹116.9
- Olvance 40 Tablet - ₹185.3
- Pinom 40 Tablet (15) - ₹274.7
- Olkem 40 Tablet (15) - ₹340.1
- Olkem 20 Tablet (15) - ₹176.16
- Olmesar 10 Tablet (15) - ₹112.1
- Olmark 20 Tablet - ₹160.6
- Olmat 20 Tablet - ₹104.5
- Olmecip 20 Tablet - ₹118.2
- Olmesar 40 Tablet (15) - ₹254.6
- Olmetime 40 Tablet - ₹101.8
- Olmetor 20 Tablet - ₹124.6
This medicine data has been created by -

B.Pharma, Pharmacy
3 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173